Prevalence of asymptomatic strongyloidiasis co-infection in COVID-19 patients residing in endemic areas.

Alireza AshiriMolouk BeiromvandAbdollah RafieiReza HeidariAmeneh Takesh

Published in: European journal of medical research (2023)

Our findings suggest that screening for latent strongyloidiasis in COVID-19 patients in endemic areas using high-sensitivity diagnostic methods, particularly ELISA, before receiving suppressive drugs should be given more consideration.

Keyphrases

sars cov
risk factors
drug induced